Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First)

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Surgical Endoscopy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00464-011-1842-7PMID 21853395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hip arthroscopy versus open surgical dislocation for femoroacetabular impingement

  2016cited by this paper
• Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies

  2011cited by this paper
• Global epidemiology of Barrett’s esophagus

  2011cited by this paper
• Effect of Helicobacter pylori Infection on Barrett’s Esophagus and Esophageal Adenocarcinoma Formation in a Rat Model of Chronic Gastroesophageal Reflux

  2011cited by this paper
• Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies

  2010cited by this paper
• A national study of Helicobactor pylori infection in gastric biopsy specimens.

  2010cited by this paper
• Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis

  2009cited by this paper
• Risk factors for esophageal cancer development.

  2009cited by this paper
• Prevalence of erosive esophagitis and Barrett’s esophagus in the adult Chinese population

  2009cited by this paper
• Esophageal Adenocarcinoma in “Mice and Men”: Back to Basics!

  2008cited by this paper
• Effect of Adiponectin and Ghrelin on Apoptosis of Barrett Adenocarcinoma Cell Line

  2008cited by this paper
• Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett's esophagus.

  2007cited by this paper
• Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.

  2007cited by this paper
• Mice and Men: Their Promoter Properties

  2006cited by this paper
• Abnormal Expression of Biomarkers in Incompletely Ablated Barrett’s Esophagus

  2006cited by this paper
• TP53 and progression from Barrett’s metaplasia to oesophageal adenocarcinoma in a UK population cohort

  2006cited by this paper
• [Barrett's esophagus and Helicobacter pylori].

  2005cited by this paper
• MUC4 is increased in high grade intraepithelial neoplasia in Barrett’s oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio

  2004cited by this paper
• Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.

  2003cited by this paper
• Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

  2002cited by this paper
• Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa

  2002cited by this paper
• Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression.

  2000cited by this paper
• Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.

  1999cited by this paper
• Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus.

  1997cited by this paper
• Barrett's oesophagus and Helicobacter pylori

  1995cited by this paper
• Absence of campylobacter-like organisms in barrett's esophagus

  1989cited by this paper
• Absence of Campylobacter-like organisms in Barrett's esophagus.

  1989cited by this paper

• Computational modeling and simulation of the Bcl-2 family: paving the way for rational drug design.

  2012cites this paper